share_log

海思科:关于获得1类创新药苯磺酸克利加巴林胶囊新适应症《药品注册证书》的公告

Haisco Pharmaceutical Group: Announcement on obtaining new indications for Type 1 innovative drug Cligabalin Hydrochloride Capsules in the Drug Registration Certificate

SZSI ·  Jul 7, 2024 09:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more